Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin
| Autor: | Mackiewicz, Z., Antti Kalle Kalervo Sukura, Povilenaite, D., Ceponis, A., Virtanen, I., Hukkanen, M., Yrjö Konttinen |
|---|---|
| Předmět: |
Adult
Male Vascular Endothelial Growth Factor A Lymphokines Scleroderma Systemic Neovascularization Pathologic Vascular Endothelial Growth Factors Raynaud Disease Endothelial Growth Factors Middle Aged Immunohistochemistry Receptors Vascular Endothelial Growth Factor Animals Humans Intercellular Signaling Peptides and Proteins Lupus Erythematosus Systemic Female Skin |
| Zdroj: | Europe PubMed Central University of Helsinki |
| Popis: | To investigate the expression of vascular endothelial growth factor (VEGF) and its vascular and lymphatic receptors in skin in systemic sclerosis (SSc) compared to systemic lupus erythematosus (SLE), Raynaud's phenomenon (RP) and normal healthy control skin.Staining was performed using rabbit anti-human antibodies in DAKO TechMate Horizon staining robot programmed for the biotin-streptavidin protocol.VEGF was sporadically and weakly expressed in normal skin, but in spite of vascular damage in diseased skin, VEGF expression was only slightly upregulated. In contrast, its vascular receptors VEGFR-1 (Flt-1) and VEGFR-2 (Flk-1), were clearly upregulated. Finally, the lymphatic VEGFR-3 (Flt-4) receptor was also upregulated in diseased skin and ectopically expressed also in blood vessels. Negative staining and positive sample controls confirmed the specificity of the staining.The imbalanced expression of VEGF and its vascular receptors suggest that the compensatory efforts to angiogenesis fail in SSc, in part due to insufficient local production of VEGF, which was low compared to VEGFR expression. This is compatible with the recent observations on the lack of alpha V beta 3+ newly formed blood vessels in SSc skin. Since microvascular angiogenic stimuli normally induce first VEGF and then VEGFR, these findings also suggest that the angiogenic cascade is turned on, but there is a defect in the finalization of its effects. Normalization of angiogenic cascade in SSc could provide a future therapeutic target. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|